Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalised Pharmaconutrition Therapy in Gastric Cancer
NCT07466758Phase 2Completed
- Sponsor
- Biruni University
- Start
- Oct 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Biruni University. Primary endpoint: Change in Skeletal Muscle Myosteatosis at the L3 Level. Started Oct 2024; status: completed.
Beyond the preview
Go deeper on NCT07466758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07466758.